Quick Answer
COSCIENS Biopharma Inc. reported Total Assets of $21.43 million for the year ending 2025.
- COSCIENS Biopharma Inc. showed a decrease of -38.9% in Total Assets from 2024 to 2025.
- This data is from COSCIENS Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), COSCIENS Biopharma Inc.'s Total Assets has declined by 32.3%.
- Historical annual values: Fiscal year 2025: $21.43 million | Fiscal year 2024: $35.07 million | Fiscal year 2023: $23.75 million | Fiscal year 2022: $37.73 million | Fiscal year 2021: $80.10 million | Fiscal year 2020: $37.01 million | Fiscal year 2019: $19.98 million | Fiscal year 2018: $25.01 million | Fiscal year 2017: $22.20 million | Fiscal year 2016: $31.66 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: